Regal Assets Analytics

SanaCurrents’ Sentiment for PDUFA decision on Krystal’s (KRYS) gene therapy B-VEC

By |2022-09-12T08:44:29-04:00September 10th, 2022|Tags: |

$KYRS Probability Sentiment SUMMARY Krystal Biotech’s B-VEC treatment for the rare skin disease dystrophic epidermolysis [...]

SanaCurrents on Eiger’s (EIGR) late stage combinations to treat hepatitis delta virus (HDV)

By |2022-09-06T07:06:35-04:00September 4th, 2022|Tags: |

Eiger Biopharmaceuticals, Inc. (NASDAQ:EIGR) Probability Sentiment SUMMARY Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) seeks to carve out [...]

SanaCurrents on Lexicon’s (LXRX) sotagliflozin challenge to treat heart failure

By |2022-08-29T10:26:30-04:00August 27th, 2022|Tags: |

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Probability Sentiment SUMMARY Once a biopharma highflyer when it was known [...]

SanaCurrents on Affimed’s (AFMD) immunotherapy in Peripheral T-cell lymphoma (PTCL)

By |2022-08-22T09:37:05-04:00August 20th, 2022|Tags: |

Affimed N.v. (NASDAQ:AFMD) Probability Sentiment SUMMARY Peripheral T-cell lymphoma (PTCL) strikes 1 in 100,000 Americans [...]

Go to Top